Hypoxia control to normalize pathologic angiogenesis: potential role for endothelial precursor cells and miRNAs regulation (Q37996791)

26 August 2017

Hypoxia control to normalize pathologic angiogenesis: potential role for endothelial precursor cells and miRNAs regulation (English)

1 reference

26 August 2017

0 references

0 references

1 reference

Guillaume Collet

1

0 references

Klaudia Skrzypek

Klaudia Skrzypek

2

0 references

Agata Matejuk

Agata Matejuk

4

0 references

Catherine Grillon

Catherine Grillon

3

0 references

Claudine Kieda

7

Claudine Kieda

1 reference

26 August 2017

Bouchra El Hafni-Rahbi

5

1 reference

PubMed ID

22446152

26 August 2017

Nathalie Lamerant-Fayel

6

1 reference

26 August 2017

8 March 2012

1 reference

26 August 2017

Vascular Pharmacology

1 reference

26 August 2017

56

1 reference

26 August 2017

5-6

1 reference

26 August 2017

252-261

1 reference

The tumour microenvironment as a target for chemoprevention.

26 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

MicroRNA-mediated regulation of the angiogenic switch

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

The multifaceted circulating endothelial cell in cancer: towards marker and target identification.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Instructive role of the vascular niche in promoting tumour growth and tissue repair by angiocrine factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Mechanisms of angiogenesis and arteriogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Molecular mechanisms and clinical applications of angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Why is the partial oxygen pressure of human tissues a crucial parameter? Small molecules and hypoxia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Nitric oxide modulates the expression of endothelial cell adhesion molecules involved in angiogenesis and leukocyte recruitment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Mesenchymal stem cells overexpressing MiR-126 enhance ischemic angiogenesis via the AKT/ERK-related pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

A cellular micro-RNA, let-7i, regulates Toll-like receptor 4 expression and contributes to cholangiocyte immune responses against Cryptosporidium parvum infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Regulation of the expression and activity of the antiangiogenic homeobox gene GAX/MEOX2 by ZEB2 and microRNA-221

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Endothelial cells as key determinants of the tumor microenvironment: interaction with tumor cells, extracellular matrix and immune killer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

MicroRNAs as biomarkers of disease onset.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Selective human endothelial cell activation by chemokines as a guide to cell homing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Immunophenotypic, cytogenetic and functional characterization of circulating endothelial cells in myelodysplastic syndromes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

microRNA-222 controls neovascularization by regulating signal transducer and activator of transcription 5A expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Bone marrow is a reservoir for proangiogenic myelomonocytic cells but not endothelial cells in spontaneous tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Endothelial and hematopoietic progenitor cells (EPCs and HPCs): hand in hand fate determining partners for cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Effects of pioglitazone versus metformin on circulating endothelial microparticles and progenitor cells in patients with newly diagnosed type 2 diabetes--a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

MicroRNA miR-93 promotes tumor growth and angiogenesis by targeting integrin-β8.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Angiogenesis as a therapeutic target

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Circulating microRNAs in patients with coronary artery disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

MicroRNAs: opening a new vein in angiogenesis research.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Role of angiogenesis in tumor growth and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

7 January 2021

Cancer without disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Myeloid-derived suppressor cells as regulators of the immune system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Factors interacting with HIF-1alpha mRNA: novel therapeutic targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Normalization of the vasculature for treatment of cancer and other diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Circulating microRNAs as biomarkers and potential paracrine mediators of cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

MicroRNAs and vascular (dys)function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Prolyl hydroxylases 2 and 3 act in gliomas as protective negative feedback regulators of hypoxia-inducible factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Microenvironmental regulation of cancer development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

MicroRNA-210 as a novel therapy for treatment of ischemic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Emodin enhances cytotoxicity of chemotherapeutic drugs in prostate cancer cells: the mechanisms involve ROS-mediated suppression of multidrug resistance and hypoxia inducible factor-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Efficient in vivo microRNA targeting of liver metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Hypoxia response and microRNAs: no longer two separate worlds.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Molecular regulation of vessel maturation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

A new target for tumor therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Effect of vascular normalization by antiangiogenic therapy on interstitial hypertension, peritumor edema, and lymphatic metastasis: insights from a mathematical model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Biomarkers of response and resistance to antiangiogenic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Derivation of endothelial cells from human embryonic stem cells by directed differentiation: analysis of microRNA and angiogenesis in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anti-cancer therapeutic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

New human microvascular endothelial cell lines with specific adhesion molecules phenotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Double antiangiogenic protein, DAAP, targeting VEGF-A and angiopoietins in tumor angiogenesis, metastasis, and vascular leakage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Vascular endothelial growth factor is a secreted angiogenic mitogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

MicroRNA-221 regulates high glucose-induced endothelial dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

The CCL21/CCR7 pathway plays a key role in human colon cancer metastasis through regulation of matrix metalloproteinase-9.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Correlation effect of EGFR and CXCR4 and CCR7 chemokine receptors in predicting breast cancer metastasis and prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Mechanisms of resistance to anti-angiogenic therapy and development of third-generation anti-angiogenic drug candidates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Circulating miR-210 predicts survival in critically ill patients with acute kidney injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Functions of CXCL12 and CXCR4 in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Protein kinases and the hypoxia-inducible factor-1, two switches in angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Involvement of chemokine receptors in breast cancer metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

EGFL7 meets miRNA-126: an angiogenesis alliance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Molecular pathways: hypoxia response in immune cells fighting or promoting cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

CD133 positive progenitor endothelial cell lines from human cord blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

The homeobox gene Gax inhibits angiogenesis through inhibition of nuclear factor-kappaB-dependent endothelial cell gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

MicroRNA function: multiple mechanisms for a tiny RNA?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Tumor vascular changes mediated by inhibition of oncogenic signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Circulating endothelial cell count as a diagnostic marker for non-ST-elevation acute coronary syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Efficient mobilization and recruitment of marrow-derived endothelial and hematopoietic stem cells by adenoviral vectors expressing angiogenic factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

CXCL12/CXCR4 blockade induces multimodal antitumor effects that prolong survival in an immunocompetent mouse model of ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

The Role of PTEN in Tumor Angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Persistent vascular normalization as an alternative goal of anti-angiogenic cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Angiogenesis in ischemic and neoplastic disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Chemokines direct endothelial progenitors into tumor neovessels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

miR-126 inhibits non-small cell lung cancer cells proliferation by targeting EGFL7.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Toll-like receptors on human mesenchymal stem cells drive their migration and immunomodulating responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

MicroRNA regulation by RNA-binding proteins and its implications for cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Bony Endothelium: Tumor-Mediated Transdifferentiation?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

AngiomiRs--key regulators of angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Tumor angiogenesis: molecular pathways and therapeutic targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Recruitment of regulatory T cells is correlated with hypoxia-induced CXCR4 expression, and is associated with poor prognosis in basal-like breast cancers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Suppression of tumor growth and metastasis by simultaneously blocking vascular endothelial growth factor (VEGF)-A and VEGF-C with a receptor-immunoglobulin fusion protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

The chemotactic interaction between CCL21 and its receptor, CCR7, facilitates the progression of pancreatic cancer via induction of angiogenesis and lymphangiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

Regulation of angiogenesis and choroidal neovascularization by members of microRNA-23~27~24 clusters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.001

10.1016/J.VPH.2012.03.001

7 January 2021

Identifiers

DOI

1 reference

26 August 2017

1 reference

PubMed ID

22446152